- Home
- IVVD vs IDR Comparison
IVVD vs IDR Comparison
Compare IVVD & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- IDR
- Stock Information
- Founded
- IVVD 2020
- IDR 1996
- Country
- IVVD United States
- IDR United States
- Employees
- IVVD N/A
- IDR N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- IVVD Health Care
- IDR Basic Materials
- Exchange
- IVVD Nasdaq
- IDR Nasdaq
- Market Cap
- IVVD 351.6M
- IDR 378.0M
- IPO Year
- IVVD 2021
- IDR N/A
- Fundamental
- Price
- IVVD $1.61
- IDR $32.10
- Analyst Decision
- IVVD Strong Buy
- IDR Strong Buy
- Analyst Count
- IVVD 5
- IDR 1
- Target Price
- IVVD $6.11
- IDR $17.50
- AVG Volume (30 Days)
- IVVD 6.2M
- IDR 897.7K
- Earning Date
- IVVD 11-07-2025
- IDR 11-07-2025
- Dividend Yield
- IVVD N/A
- IDR N/A
- EPS Growth
- IVVD N/A
- IDR 57.55
- EPS
- IVVD N/A
- IDR 0.64
- Revenue
- IVVD $46,210,000.00
- IDR $30,496,328.00
- Revenue This Year
- IVVD $102.11
- IDR $21.91
- Revenue Next Year
- IVVD $151.51
- IDR $5.47
- P/E Ratio
- IVVD N/A
- IDR $50.33
- Revenue Growth
- IVVD 1941.08
- IDR 59.64
- 52 Week Low
- IVVD $0.35
- IDR $9.67
- 52 Week High
- IVVD $2.74
- IDR $54.70
- Technical
- Relative Strength Index (RSI)
- IVVD 46.79
- IDR 44.37
- Support Level
- IVVD $1.74
- IDR $28.63
- Resistance Level
- IVVD $2.00
- IDR $35.25
- Average True Range (ATR)
- IVVD 0.24
- IDR 3.86
- MACD
- IVVD -0.06
- IDR -1.24
- Stochastic Oscillator
- IVVD 1.33
- IDR 13.85
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.